DiaMedica Therapeutics (DMAC) Short Interest Ratio & Short Volume → Trump Reveals Conspiracy Behind Fed-Controlled Digital Currency. (From Monetary Gold) (Ad) Free DMAC Stock Alerts $3.01 -0.01 (-0.33%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media DiaMedica Therapeutics Short Interest DataCurrent Short Volume182,000 sharesPrevious Short Volume175,400 sharesChange Vs. Previous Month+3.76%Dollar Volume Sold Short$469,560.00Short Interest Ratio / Days to Cover4.3Last Record DateApril 30, 2024Outstanding Shares37,960,000 sharesPercentage of Shares Shorted0.48%Today's Trading Volume12,225 sharesAverage Trading Volume42,528 sharesToday's Volume Vs. Average29% Short Selling DiaMedica Therapeutics ? Sign up to receive the latest short interest report for DiaMedica Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatDMAC Short Interest Over TimeDMAC Days to Cover Over TimeDMAC Percentage of Float Shorted Over Time Ad Birch GoldWATCH: The Truth About InflationThe full story on inflation is being CENSORED by the powers that be. But I have the REAL monthly numbers. And they are going to anger you. (Especially if you have money sitting in a 401k or IRA.)WATCH: The Truth About Inflation DiaMedica Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024182,000 shares $469,560.00 +3.8%N/A4.3 $2.58 4/15/2024175,400 shares $419,206.00 -13.3%N/A4.4 $2.39 3/31/2024202,200 shares $560,094.00 -4.9%N/A4.8 $2.77 3/15/2024212,600 shares $644,178.00 +8.3%N/A5 $3.03 2/29/2024196,300 shares $588,900.00 +3.7%N/A4.7 $3.00 2/15/2024189,300 shares $567,900.00 -3.3%N/A4.4 $3.00 Get the Latest News and Ratings for DMAC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for DiaMedica Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024195,700 shares $551,874.00 -3.1%N/A4 $2.82 1/15/2024202,000 shares $603,980.00 +7.0%N/A4 $2.99 12/31/2023188,800 shares $536,192.00 -2.2%N/A3.8 $2.84 12/15/2023193,100 shares $531,025.00 +5.4%N/A3.7 $2.75 11/30/2023183,300 shares $447,252.00 -24.9%N/A3.1 $2.44 11/15/2023244,200 shares $598,290.00 0.0%N/A4 $2.45 10/31/2023244,300 shares $532,574.00 +11.5%N/A4 $2.18 10/15/2023219,100 shares $449,155.00 -1.1%N/A2.9 $2.05 9/30/2023221,500 shares $571,470.00 +0.7%N/A2.3 $2.58 9/15/2023219,900 shares $712,476.00 -0.8%N/A1.8 $3.24 8/31/2023221,700 shares $654,015.00 -9.4%N/A1.5 $2.95 8/15/2023244,600 shares $725,239.00 -10.6%N/A1.5 $2.97 7/31/2023273,500 shares $924,430.00 -65.7%N/A1.6 $3.38 7/15/2023796,100 shares $3.01 million +11.6%4.5%5.4 $3.78 6/30/2023713,600 shares $3.08 million +910.8%4.0%5.4 $4.32 6/15/202370,600 shares $224,508.00 +7.1%0.4%0.7 $3.18 5/31/202365,900 shares $179,907.00 -21.2%0.4%1.1 $2.73 5/15/202383,600 shares $166,196.80 -9.0%0.5%1.9 $1.99 4/30/202391,900 shares $149,797.00 -5.7%0.5%3.4 $1.63 4/15/202397,400 shares $155,840.00 +6.5%0.6%3.4 $1.60 3/31/202391,500 shares $139,995.00 +55.6%0.5%2.9 $1.53 3/15/202358,800 shares $104,664.00 +44.8%0.4%1.5 $1.78 2/28/202340,600 shares $70,238.00 -1.7%0.3%0.7 $1.73 2/15/202341,300 shares $62,363.00 +22.6%0.3%0.7 $1.51 1/31/202333,700 shares $45,495.00 -57.8%0.2%0.5 $1.35 1/15/202379,800 shares $130,872.00 -6.5%0.5%1.2 $1.64 12/30/202285,300 shares $134,782.53 +113.8%0.5%1.3 $1.58 12/15/202239,900 shares $60,249.00 -7.0%0.2%0.6 $1.51 11/30/202242,900 shares $51,051.00 +24.4%0.2%0.7 $1.19 11/15/202234,500 shares $39,330.00 -35.0%0.2%0.6 $1.14 10/31/202253,100 shares $62,658.00 -47.5%0.3%0.9 $1.18 10/15/2022101,200 shares $153,824.00 +245.4%0.6%1.9 $1.52 9/30/202229,300 shares $36,332.00 -61.7%0.2%0.4 $1.24 9/15/202276,500 shares $110,925.00 +153.3%0.4%0.5 $1.45Democrats Push to Replace Dollar With Digital Coin, Control Currency. (Ad)Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. DMAC Short Interest - Frequently Asked Questions What is DiaMedica Therapeutics' current short interest? Short interest is the volume of DiaMedica Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 182,000 shares of DMAC short. Learn More on DiaMedica Therapeutics' current short interest. What is a good short interest ratio for DiaMedica Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DMAC shares currently have a short interest ratio of 4.0. Learn More on DiaMedica Therapeutics's short interest ratio. Which institutional investors are shorting DiaMedica Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of DiaMedica Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is DiaMedica Therapeutics' short interest increasing or decreasing? DiaMedica Therapeutics saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 182,000 shares, an increase of 3.8% from the previous total of 175,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does DiaMedica Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to DiaMedica Therapeutics: Coya Therapeutics, Inc. (1.41%), Vistagen Therapeutics, Inc. (4.86%), Nuvectis Pharma, Inc. (13.15%), FibroGen, Inc. (6.96%), Adagene Inc. (0.04%), Immunic, Inc. (3.13%), Amylyx Pharmaceuticals, Inc. (18.07%), Abeona Therapeutics Inc (12.94%), OptiNose, Inc. (5.24%), Rezolute, Inc. (0.78%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short DiaMedica Therapeutics stock? Short selling DMAC is an investing strategy that aims to generate trading profit from DiaMedica Therapeutics as its price is falling. DMAC shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against DiaMedica Therapeutics? A short squeeze for DiaMedica Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of DMAC, which in turn drives the price of the stock up even further. How often is DiaMedica Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DMAC, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Coya Therapeutics Short Interest Vistagen Therapeutics Short Interest Nuvectis Pharma Short Interest FibroGen Short Interest Adagene Short Interest Immunic Short Interest Amylyx Pharmaceuticals Short Interest Abeona Therapeutics Short Interest OptiNose Short Interest Rezolute Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DMAC) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTop 5 AI Stocks to Buy for 2024Market Moving TrendsDoes this make you sick?Allegiance Gold